← Back
Data updated: Mar 10, 2026
HERITAGE
CardiovascularGastroenterologyInfectious Disease
HERITAGE is a generic drug manufacturer focused on Cardiovascular, Gastroenterology, Infectious Disease. Key products include TRANEXAMIC ACID.
1978
Since
32
Drugs
-
Trials
328
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
DOXYCYCLINE HYCLATE 2026-02-19
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
NYSTATIN 2026-02-05
VENLAFAXINE HYDROCHLORIDE 2026-01-30
Labeling
SERTRALINE HYDROCHLORIDE 2026-01-29
SERTRALINE HYDROCHLORIDE 2026-01-28
DOXYCYCLINE HYCLATE 2026-01-26
Labeling
TRANEXAMIC ACID 2026-01-26
TEMOZOLOMIDE 2026-01-22
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 33%
3 drugs
Gastroenterology 22%
2 drugs
Infectious Disease 22%
2 drugs
Metabolic 11%
1 drugs
Neurology 11%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Merck big-pharma
Infectious Disease, Cardiovascular, Metabolic
Novo Nordisk big-pharma
Metabolic, Cardiovascular, Infectious Disease, Neurology
Johnson & Johnson big-pharma
Infectious Disease, Cardiovascular, Metabolic
AZURITY specialty
Cardiovascular, Neurology, Metabolic, Infectious Disease
WARNER CHILCOTT LLC specialty
Cardiovascular, Neurology, Gastroenterology, Infectious Disease
Active (19)
TRANEXAMIC ACID TEMOZOLOMIDE AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE VENLAFAXINE HYDROCHLORIDE SERTRALINE HYDROCHLORIDE LEFLUNOMIDE OCTREOTIDE ACETATE GLYBURIDE AND METFORMIN HYDROCHLORIDE PENTOXIFYLLINE PAROMOMYCIN SULFATE ACYCLOVIR GLYBURIDE BACLOFEN DESIPRAMINE HYDROCHLORIDE VERAPAMIL HYDROCHLORIDE DOXYCYCLINE NYSTATIN DOXYCYCLINE HYCLATE HYDROCHLOROTHIAZIDE
Discontinued (13)
Company Info
- First Approval
- 1978-01-20
- Latest
- 2025-10-24
- Applications
- 37